鶹Ӱ

Skip to Main Content

Our Innovations

Issued Patents

  • - 11/14/2023 - June Mayor, Ronald Kaplin, Shivaputra Patil - Chromenopyridine-based Compounds and Methods of Making and Use Thereof
  • - 10/17/2023 - Johnny He - Methods of Treating HIV-Associated Neurological Disorders (Hand)
  • - 1/24/2023 - Joanna Dabrowska - System and Method for Determining a Discrimination Index for Fear-Potentiated Startle
  • - 1/11/2022 -Kwang Poo Chang, et al. - Immunotherapy of Canine Leishmaniasis
  • - 9/14/2021 - Michelle Hastings - Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
  • - 11/3/2020 - Jun-Yong Choe, et al. - Human GLUT5 Specific Inhibitor Using Virtual Screening and in Vitro Transport Evaluation
  • - 9/29/2020 - Michelle Hastings, et al. - Antisense Compounds Targeting Leucine-RICH Repeat Kinase 2 (LRRL2) for the Treatment of Parkinson Disease
  • - 8/4/2020 - Lin Fang and Sai Yalla - Mobile Sensor System and Methods for Use
  • - 7/28/2020 - Noah Rosenblatt, Ryan Crews, et al. - Intelligent Offloading Insole Device
  • - 1/28/2020 - Michelle Hastings - Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
  • - 1/24/2020 - Michelle Hastings - Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
  • - 11/12/2019 - Michelle Hastings, et al. - Antisense Compounds Targeting Apolipoprotein E Receptor 2 (Alzheimer)
  • - 8/6/2019 - Michelle Hastings, et al. - Antisense Compounds Targeting Leucine-RICH Repeat Kinase 2 (LRRL2) for the Treatment of Parkinson Desease
  • - 9/11/2018 - Kwang Poo Chang - Photodynamic Insecticides
  • - 7/24/2018 - Bruce Riser - Method and Kit for Treating a Solid Tumor and Associated Desmoplasia
  • - 7/16/2019 -  Bruce Riser - CCN3 and CNN3 Peptides and Analogs Thereof for Therapeutic Use
  • - 7/3/2018 - Grace Stutzmann - Compounds for Stabilizing Ryanodine Receptors from Aberrant Levels of Calcium Release  
  • - 5/15/2018 - Judith Potashkin - Methods and Kits for Diagnosing, Prognosing and Monitoring Parkinsons Disease
  • - 12/12/2017 - Karen Stevens - Foot-Strength Test Device and Methods for Use
  • - 12/12/2017 -  Michelle Hastings - Antisense Compounds Targeting Genes Associated With Cystic Fibrosis
  • - 12/12/2017 -  Michelle Hastings - Antisense Compounds Targeting Leucine-RICH Repeat Kinase 2 (LRRL2) for the Treatment of Parkinson Desease
  • - 11/28/2017 -  Bijan Najafi, et al. - Providing Visual Motion Feedback Based on Sensor Data
  • - 8/8/2017 - Grace Stutzmann - Furan-based Compounds for Stabilizing Ryanodine Receptors from Aberrant Levels of Calcium Release and Method for Treating Alzheimer's Disease with these Compounds
  • - 1/31/2017 - Michelle Hastings - Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome
  • - 1/3/2017 - Darryl Peterson - A method and kit for administering gamma-glutamyl-D-cysteine for the prevention of reperfusion injury following ischemic stroke  
  • - 5/31/2016 - Michelle Hastings, et al. - Antisense Compounds Targeting Genes Associated with usher syndrome
  •  - 5/3/2016 - Kwang-Poo Chang, Sujoy Dutta - Leishmania-based carrier for vaccine delivery
  • - 8/25/2015 - Bruce Riser - CNN3 and CNN3 peptides and analogs thereof for therapeutic use
  • - 8/11/2015 - Grace Stutzman - Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
  • - 3/17/2015 - Bijan Najafi, et al. - Providing Motion Feedback Based on User Center of Mass
  • - 9/23/2014 -Judith Potashkin, et al. - Screening, diagnosing, treating and prognosis of pathophysiologic status by RNA regulation
  • - 7/8/2014 - Judith Potashkin - Splice variant specific messenger RNA transcripts as biomarkers of Parkinson's disease
  • - 6/17/2014 - Bijan Najafi, et al. - Intelligent Device to Monitor And Remind Patients With Footwear, Walking Aids, Braces, Or Orthotics
  • - 2/11/2014 - Michelle Hastings - Antisense oligonucleotides that target a cryptic splice site in USH1C as a therapeutic for usher syndrome
  • - 8/27/2013 - Darryl Peterson - Cytoprotective therapeutic agents for the prevention of reperfusion injury following ischemic stroke
  • - 8/27/2013 - Bruce Riser - CCN3 peptides and analogs thereof for therapeutic use 
  • - 3/13/2012 - Raul Gazmuri - Facilitation of resuscitation from cardiac arrest by erythropoietin
  • - 1/31/2012 - Erin Klein, et al. - Extremity stress attenuation modality with resistance-mechanism engaging member
  • - 11/29/2011 - Raul Gazmuri - Facilitation of resuscitation from cardiac arrest by erythropoietin
  • - 6/7/2011 - Darryl Peterson - Cytoprotective therapeutic agents for the prevention of reperfusion injury following ischemic stroke 
  • - 8/24/2010 - Bruce Riser - Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases
  • - 8/28/2007 - Kwang-Poo Chang, Sujoy Dutta. - Leishmania as carriers for the delivery of proteins and peptides 
  • - 7/3/2007 - Kwang-Poo Chang, Sujoy Dutta. - Suicidal mutant Leishmania vaccine 

Pending Patents

  • - 9/13/2021 - Michelle Hastings - Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
  • - 9/10/2021 - Michelle Hastings - Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
  • - 7/9/2021 - Raul Gazmuri - Gliflozins and a Method for their Delivery during Resuscitation from Cardiac Arrest to Improve Survival Outcomes
  • - 3/10/2021 - Michelle Hastings, et al. - Compounds and Methods For Modulating CLN3 Expression
  • - 9/2/2020 - Michelle Hastings, et al. - Compounds and Methods for the Modulation of Amyloid Beta Precursor Protein
  • - 5/29/2020 - Kwang Poo Chang - Immunotherapy of Solid Tumors by Vaccination with Transgenicleishmania Expressing Cancer Vaccines
  • - 7/15/2019 - Bruce Riser - CCN3 and CCN3 Peptides and Analogs Thereof for Therapeutic Use
  • - 10/8/2020 - Jun-Yong Choe, et al. - Variant of Gala Reductase and their Uses
  • - 8/9/2019 - Michelle Hastings, et al. - Antisense Compounds Targeted to CLN3 and Uses Thereof